
The FDA gave speedy approval for the clinical trial of famotidine, the active ingredient in Pepcid, without proof of its efficacy against COVID-19.
That contract is now under scrutiny after a government whistleblower accused a senior administration official of rushing the deal through without the scientific oversight necessary for such a significant federal award. And the doctors who initially promoted the Pepcid idea are fighting a battle for credit and sniping over allegations of scientific misconduct.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.
Copied!